GSK Presents Phase 2b Data on Linerixibat for the Treatment of Cholestatic Pruritus in Primary Biliary Cholangitis (PBC)
13 November 2020 — GlaxoSmithKline plc (GSK) today announced further progression in its R&D pipeline with presentation of data for …